156 related articles for article (PubMed ID: 28338133)
1. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
2. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
Plazinska A; Plazinski W; Jozwiak K
J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
[TBL] [Abstract][Full Text] [Related]
3. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
4. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
[TBL] [Abstract][Full Text] [Related]
5. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
[TBL] [Abstract][Full Text] [Related]
6. The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.
Jozwiak K; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Biochem Pharmacol; 2010 Jun; 79(11):1610-5. PubMed ID: 20144591
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
[TBL] [Abstract][Full Text] [Related]
8. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
Plazinska A; Plazinski W; Jozwiak K
Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
[TBL] [Abstract][Full Text] [Related]
9. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
Reinartz MT; Kälble S; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
11. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
[TBL] [Abstract][Full Text] [Related]
13. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
Isin B; Estiu G; Wiest O; Oltvai ZN
PLoS One; 2012; 7(12):e50186. PubMed ID: 23300522
[TBL] [Abstract][Full Text] [Related]
14. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
15. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
Chan HC; Filipek S; Yuan S
Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
[TBL] [Abstract][Full Text] [Related]
16. Cell-based assays and molecular dynamics analysis of a boron-containing agonist with different profiles of binding to human and guinea pig beta2 adrenoceptors.
Soriano-Ursúa MA; Bello M; Hernández-Martínez CF; Santillán-Torres I; Guerrero-Ramírez R; Correa-Basurto J; Arias-Montaño JA; Trujillo-Ferrara JG
Eur Biophys J; 2019 Jan; 48(1):83-97. PubMed ID: 30386878
[TBL] [Abstract][Full Text] [Related]
17. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.
Plazinska A; Pajak K; Rutkowska E; Jimenez L; Kozocas J; Koolpe G; Tanga M; Toll L; Wainer IW; Jozwiak K
Bioorg Med Chem; 2014 Jan; 22(1):234-46. PubMed ID: 24326276
[TBL] [Abstract][Full Text] [Related]
18. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
Vilar S; Karpiak J; Berk B; Costanzi S
J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234
[TBL] [Abstract][Full Text] [Related]
19. Potential Application of Alchemical Free Energy Simulations to Discriminate GPCR Ligand Efficacy.
Lee HS; Seok C; Im W
J Chem Theory Comput; 2015 Mar; 11(3):1255-66. PubMed ID: 26579772
[TBL] [Abstract][Full Text] [Related]
20. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.
Reinartz MT; Kälble S; Littmann T; Ozawa T; Dove S; Kaever V; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):51-65. PubMed ID: 25342094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
